MedTrace Logo

Randomized Trial of Treatments for Convergence Insufficiency

NCT00347945 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2006-07-04

No results posted yet for this study

Summary

The Convergence Insufficiency Treatment Trial (CITT) is a multi-center, placebo-controlled, single-masked, clinical trial designed to compare the benefits of two commonly used treatment approaches for patients with convergence insufficiency (CI)

Conditions

  • Convergence Insufficiency

Interventions

PROCEDURE

Pencil Push-ups

PROCEDURE

Office-based Vision Therapy

PROCEDURE

Placebo Office-based Vision Therapy

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Pennsylvania College of Optometry

    lead INDUSTRY

Principal Investigators

  • Mitchell Scheiman, OD · Pennsylvania College of Optometry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
9 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-10-31
Completion
2001-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00347945 on ClinicalTrials.gov